Raia Drogasil S.A. (RADLY)

OTCMKTS · Delayed Price · Currency is USD
4.510
-0.054 (-1.18%)
At close: Mar 27, 2026
Market Cap7.77B +42.1%
Revenue (ttm)8.03B +13.8%
Net Income235.45M +8.1%
EPS0.14 +10.0%
Shares Outn/a
PE Ratio32.99
Forward PE23.32
Dividend0.06 (1.25%)
Ex-Dividend DateDec 15, 2025
Volume1,419
Average Volume16,245
Open4.525
Previous Close4.564
Day's Range4.510 - 4.525
52-Week Range2.167 - 5.342
Beta0.16
RSI44.05
Earnings DateMar 3, 2026

About Raia Drogasil

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil. [Read more]

Sector Healthcare
Founded 1905
Employees 73,895
Stock Exchange OTCMKTS
Ticker Symbol RADLY

Financial Performance

In 2025, Raia Drogasil's revenue was 44.25 billion, an increase of 13.84% compared to the previous year's 38.87 billion. Earnings were 1.30 billion, an increase of 8.08%.

Financial numbers in BRL Financial Statements

News

Raia Drogasil SA (RADLY) Q4 2025 Earnings Call Highlights: Record Growth and Strategic Shifts

Raia Drogasil SA (RADLY) Q4 2025 Earnings Call Highlights: Record Growth and Strategic Shifts

19 days ago - GuruFocus

Q4 2025 Raia Drogasil S/A Earnings Call (English, Portuguese) Transcript

Q4 2025 Raia Drogasil S/A Earnings Call (English, Portuguese) Transcript

19 days ago - GuruFocus